Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
- Status
- COMPLETED
- Phase
- NA
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Assessment of QoL and Outcomes With SBRT for RCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison Between Partial Nephrectomy and Ablation for Renal Tumor
- Status
- UNKNOWN
- Phase
- NA
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Everolimus TDM to Predict Long Term Toxicity
- Status
- UNKNOWN
- Phase
- N/A
An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2